ebastin orifarm 10 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 10 mg
ebastin orifarm 20 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 20 mg
kestine 20 mg
almirall, s.a. - ebastin - tablett, filmdrasjert - 20 mg
kestine 10 mg
almirall, s.a. - ebastin - tablett, filmdrasjert - 10 mg
livostin 50 mikrog/ dose
mcneil sweden ab - levokabastinhydroklorid - nesespray, suspensjon - 50 mikrog/ dose
livostin 0.5 mg/ ml
mcneil sweden ab - levokabastinhydroklorid - Øyedråper, suspensjon - 0.5 mg/ ml
kestine 10 mg
2care4 aps - ebastin - tablett, filmdrasjert - 10 mg
kestine 20 mg
2care4 aps - ebastin - tablett, filmdrasjert - 20 mg
livostin 50 mikrog/ dose
2care4 aps - levokabastinhydroklorid - nesespray, suspensjon - 50 mikrog/ dose
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.